Stocks and Investing
Stocks and Investing
Tue, May 5, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, May 4, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Robert Burns Initiated (BDTX) at Strong Buy and Held Target at $53 on, May 4th, 2020
Robert Burns of HC Wainwright & Co., Initiated "Black Diamond Therapeutics, Inc." (BDTX) at Strong Buy and Held Target at $53 on, May 4th, 2020.
Robert has made no other calls on BDTX in the last 4 months.
There are 4 other peers that have a rating on BDTX. Out of the 4 peers that are also analyzing BDTX, 0 agree with Robert's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Robert
- Arlinda Lee of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $50 on, Monday, February 24th, 2020
- Eric Joseph of "JP Morgan" Initiated at Buy and Held Target at $42 on, Monday, February 24th, 2020
- Marc Frahm of "Cowen & Co." Initiated at Buy on, Monday, February 24th, 2020
- Maury Raycroft of "Jefferies" Initiated at Strong Buy and Held Target at $47 on, Monday, February 24th, 2020